top of page
Online News Reading

News and Links

Scientific Publications

Rescue of Transgenic Alzheimer’s Pathophysiology by Polymeric Cellular Prion Protein Antagonists

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358723/pdf/nihms-1517844.pdf

​

Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2649699/pdf/nihms-95394.pdf

Intellectual Property

U.S. Patent 9,095,126

US9095126B2 - Targeting TGF-β as a therapy for Alzheimer's disease

https://patents.google.com/patent/US9095126B2/en?oq=9%2c095%2c126

​

Pending Patent: US 62/694710

Memories.png

Join Us in the Fight:

Temple Street Biotech invites you to join us on this critical journey. Together, we can rewrite the story of Alzheimer's disease, offering hope and tangible solutions to those affected. With Temple Street Biotech, the future of Alzheimer's treatment is brighter than ever. Together, we are pioneering progress, one discovery at a time.

Join our mailing list for updates

Thanks for submitting!

Temple Street Biotech

15 East Putnam Avenue, Suite 363, Greenwich, CT 06830

© 2024 Temple Street Biotech, Inc. All rights reserved.

bottom of page